A randomized, double-blind, placebo-controlled trial was conducted to determine the benefit
of nabilone in pain management and quality of life improvement in 40 patients with …

Nabilone, a synthetic cannabinoid, is approved in many countries including, but not limited
to, Canada, the United States, Mexico, and the United Kingdom for the treatment of severe …

OBJECTIVE: The aim of this study was to investigate the efficacy and efficiency of an add-on
treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain. Of …

Objective To compare the analgesic efficacy and side effects of the synthetic cannabinoid
nabilone with those of the weak opioid dihydrocodeine for chronic neuropathic pain. Design …

BACKGROUND: Sleep disorders affect many patients with chronic pain conditions.
Cannabis has been reported by several patient populations to help sleep. We evaluated the …

About 30% of patients with chronic upper motor neuron syndrome (UMNS) suffer from
disabling spasticity-related pain not sufficiently correctable by conventional treatment …

Chronic noncancer pain includes a heterogenous group of disorders and is often refractory
to treatment. Cannabis products have historically been used for chronic pain and are …

Neuropathic pain (NeP) is prevalent in patients with peripheral neuropathy (PN), regardless
of etiology. We sought to compare the efficacy of the cannabinoid nabilone as either …

Medication overuse headache (MOH) is a severe burden to sufferers and its treatment has
few evidence-based indications. The aim of this study is to evaluate efficacy and safety of …

Background Neuropathic pain (NPP) is a chronic syndrome suffered by patients with
multiple sclerosis (MS), for which there is no cure. Underlying cellular mechanisms involved …